HRS-2129 placebo
Sponsors
Shandong Suncadia Medicine Co., Ltd.
Conditions
Diabetic Peripheral Neuropathic PainPainPostoperative Pain in Orthopaedics
Phase 1
A Single Dose Escalation Trial of HRS-2129 in Healthy Subjects
CompletedNCT06619392
Start: 2024-10-17End: 2025-01-20Updated: 2025-03-05
A Multiple Ascending Dose Trial of HRS-2129 in Healthy Subjects
CompletedNCT06742840
Start: 2024-12-30End: 2025-07-02Updated: 2025-09-03
Clinical Study of HRS-2129 for Postoperative Analgesia in Orthopaedics
CompletedNCT06780267
Start: 2025-03-11End: 2026-04-03Updated: 2026-06-02
A Study of HRS-2129 in Patients With Diabetic Peripheral Neuropathic Pain
RecruitingNCT07377721
Start: 2026-03-24End: 2026-11-01Target: 168Updated: 2026-04-15